Tag Archives: Bextra

Proposed Avandia Settlement Would Pay U.S. $3B for Off-Label Marketing

  • Written by: Staff Writers

GlaxoSmithKline and the federal government have reached a tentative $3 billion settlement over Avandia marketing charges, alleging that the company promoted the controversial and dangerous diabetes drug for uses that were not approved by the FDA or determined to be safe and effective. …

Dilantin Stevens-Johnson Syndrome Lawsuit Filed by Three People

  • Written by: Staff Writers

A Stevens-Johnson syndrome lawsuit has been filed in Illinois against the makers of the epilepsy drug Dilantin, by two people who developed the debilitating skin reaction after taking the drug, and the family of a third person who died as a result of the condition.…

FDA Bans KV Pharmaceuticals CEO from Industry

In a move that may signal an increasing willingness to get tough on pharmaceutical company executives, federal regulators have banned the former CEO of a generic drug manufacturer from doing business with federal health care programs. …

DOJ to Intervene in Rapamune Whistleblower Lawsuit Against Pfizer

  • Written by: Staff Writers
  • 1 Comment

The federal government and a number of states have decided to intervene in a whistleblower lawsuit that accuses Pfizer’s Wyeth unit of giving kickbacks to doctors to encourage them to prescribe Rapamune, as well as promoting the organ transplant drug for off-label uses. …

Contact A Lawyer

Contact A Lawyer

Have A Potential Case Reviewed By An Attorney

  • This field is for validation purposes and should be left unchanged.